Evidence map›Paper›PMID 26038588›Full record

ReviewEuropean heart journal2015

Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments.

Colin Berry, David Corcoran, Barry Hennigan, Stuart Watkins, Jamie Layland, Keith G Oldroyd

Registry-linked trialAbstract readReview
In one paragraph

Review in European heart journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01764334 (A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01764334 phase4unknown statusnot on this map

A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI.

TypeinterventionalSponsorNHS National Waiting Times Centre BoardRan2011 to 2020Enrolled350ConditionsNonST Elevation Myocardial Infarction, Myocardial InfarctionArmsFractional flow reserve
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes.Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNADrug design, development and therapy · 2020
    Article
  18. Long Noncoding RNABioMed research international · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Colin BerryWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK colin.berry@glasgow.ac.uk.
David CorcoranWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Barry HenniganWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK.
Stuart WatkinsWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK.
Jamie LaylandSt Vincent's Hospital, Melbourne, Australia.
Keith G OldroydWest of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK.

Funding

British Heart Foundation FS/14/15/30661British Heart Foundation PG/11/55/28999British Heart Foundation PG/14/97/31263Medical Research Council MR/N003403/1
6 · The paper itself

Abstract

Coronary artery disease (CAD) is a leading global cause of morbidity and mortality, and improvements in the diagnosis and treatment of CAD can reduce the health and economic burden of this condition. Fractional flow reserve (FFR) is an evidence-based diagnostic test of the physiological significance of a coronary artery stenosis. Fractional flow reserve is a pressure-derived index of the maximal achievable myocardial blood flow in the presence of an epicardial coronary stenosis as a ratio to maximum achievable flow if that artery were normal. When compared with standard angiography-guided management, FFR disclosure is impactful on the decision for revascularization and clinical outcomes. In this article, we review recent developments with FFR in patients with stable CAD and recent myocardial infarction. Specifically, we review novel developments in our understanding of CAD pathophysiology, diagnostic applications, prognostic studies, clinical trials, and clinical guidelines.

Indexed as

Acute Coronary SyndromeAdenosineAge FactorsBlood Pressure DeterminationCardiac Imaging TechniquesCentral Venous PressureCoronary DiseaseCoronary StenosisForecastingFractional Flow Reserve, MyocardialHumansInfusions, IntravenousMulticenter Studies as TopicMyocardial InfarctionPractice Guidelines as TopicRandomized Controlled Trials as TopicAdenosineVasodilator AgentsCoronary revascularizationFractional flow reserveMedical therapyMyocardial infarctionStable angina

Identifiers

PMID26038588
PMCPMC4816759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.